December 04, 2024 11:54 GMT
HEALTHCARE: Eli Lilly beating Novo Nordisk
HEALTHCARE
NBC Reports: "According to Lilly’s trial results, patients who got weekly injections of Zepbound lost an average 20.2% of their body weight, or 50.3 pounds, after 72 weeks, compared with an average of 13.7% body weight, or 33.1 pounds, for those who got Wegovy.
That means, Lilly says, Zepbound provides 47% more weight loss than Wegovy."
55 words